INTUITIVE SURGICAL INC

Intuitive Surgical develops and provides robotic-assisted surgical platforms and diagnostic technologies designed to advance minimally invasive healthcare. The company manufactures the da Vinci surgical system for a wide range of soft-tissue procedures and the Ion endoluminal system for minimally invasive lung biopsies. Beyond primary robotic hardware, its portfolio encompasses specialized instruments, advanced stapling and energy tools, sterile accessories, educational simulation software, and analytics services. Intuitive primarily serves hospitals, healthcare systems, surgeons, and procedural care teams across general surgery, urology, gynecology, cardiothoracic, and head and neck specialties.

The company deploys its surgical and diagnostic platforms internationally across the United States and global markets. Intuitive supports its customer base through an infrastructure of field service engineers situated throughout the United States, Canada, Europe, and Asia, alongside distributor partnerships worldwide. The organization also maintains dedicated training centers where staff instruct clinicians and care teams on its technologies. The provided text does not mention the location of the company's headquarters.

Summary of the business section of Intuitive Surgical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had approximately 17,021 full-time employees, with approximately 2,288 in research and development, 7,625 in manufacturing operations, 4,837 in commercial and service operations, and 2,271 in administrative activities.”